Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma

Tekijä Ogura, Michinori, Ishida, Takashi, Tsukasaki, Kunihiro, Takahashi, Takeshi, Utsunomiya, Atae
Julkaisussa Cancer Chemother Pharmacol (2016)

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

Tekijä Izutsu, Koji, Ogura, Michinori, Tobinai, Kensei, Hatake, Kiyohiko, Sakamoto, Shigeru, Nishimura, Masanori, Hoshino, Miyako
Julkaisussa Int J Hematol (2021)

E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma: A phase I study

Tekijä Ohmachi, Ken, Ando, Kiyoshi, Ogura, Michinori, Uchida, Toshiki, Tobinai, Kensei, Maruyama, Dai, Namiki, Masayuki, Nakanishi, Tadashi
Julkaisussa Cancer Sci (2018)

Phase I study of anti‐CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B‐cell non‐Hodgkin lymphoma

Tekijä Ogura, Michinori, Hatake, Kiyohiko, Ando, Kiyoshi, Tobinai, Kensei, Tokushige, Kota, Ono, Chiho, Ishibashi, Taro, Vandendries, Erik
Julkaisussa Cancer Sci (2012)

A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy

Tekijä Maloney, David G., Ogura, Michinori, Fukuhara, Noriko, Davis, Jaclyn, Lasher, Janet, Izquierdo, Miguel, Banerjee, Hiya, Tobinai, Kensei
Julkaisussa Blood Adv (2020)

Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome

Tekijä Ueda, Yasunori, Ogura, Michinori, Miyakoshi, Shigesaburo, Suzuki, Takahiro, Heike, Yuji, Tagashira, Shuzo, Tsuchiya, Satoru, Ohyashiki, Kazuma, Miyazaki, Yasushi
Julkaisussa Cancer Sci (2017)

Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma

Tekijä Tateishi, Ukihide, Tatsumi, Mitsuaki, Terauchi, Takashi, Ando, Kiyoshi, Niitsu, Nozomi, Kim, Won Seog, Suh, Cheolwon, Ogura, Michinori, Tobinai, Kensei
Julkaisussa Cancer Sci (2015)

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma

Tekijä Ogura, Michinori, Tobinai, Kensei, Hatake, Kiyohiko, Uchida, Toshiki, Suzuki, Tatsuya, Kobayashi, Yukio, Mori, Masakazu, Terui, Yasuhito, Yokoyama, Masahiro, Hotta, Tomomitsu
Julkaisussa Cancer Sci (2012)

Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer‐cell malignancies

Tekijä Ogura, Michinori, Tsukasaki, Kunihiro, Nagai, Hirokazu, Uchida, Toshiki, Oyama, Takashi, Suzuki, Tatsuya, Taguchi, Jun, Maruyama, Dai, Hotta, Tomomitsu, Tobinai, Kensei
Julkaisussa Cancer Sci (2012)

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea

Tekijä Ogura, Michinori, Kim, Won-Seog, Uchida, Toshiki, Uike, Naokuni, Suehiro, Youko, Ishizawa, Kenichi, Nagai, Hirokazu, Nagahama, Fumiko, Sonehara, Yusuke, Tobinai, Kensei
Julkaisussa Jpn J Clin Oncol (2020)

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel – an update

Tekijä Cheson, Bruce D., Brugger, Wolfram, Damaj, Gandhi, Dreyling, Martin, Kahl, Brad, Kimby, Eva, Ogura, Michinori, Weidmann, Eckhart, Wendtner, Clemens-Martin, Zinzani, Pier Luigi
Julkaisussa Leuk Lymphoma (2016)

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Tekijä Ogura, Michinori, Hatake, Kiyohiko, Tobinai, Kensei, Uchida, Toshiki, Suzuki, Tatsuya, Terui, Yasuhito, Yokoyama, Masahiro, Maruyama, Dai, Mori, Masakazu, Jewell, Roxanne C., Katsura, Koichi, Hotta, Tomomitsu
Julkaistu 2013

Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma

Tekijä Sangha, Randeep, Davies, Andrew, Dang, Nam H., Ogura, Michinori, MacDonald, David A., Ananthakrishnan, Revathi, Paccagnella, M. Luisa, Vandendries, Erik, Boni, Joseph, Goh, Yeow Tee
Julkaisussa J Drug Assess (2017)

Phenotypic and Genotypic Lineage Switch of a Lymphoma with Shared Chromosome Translocation and T‐Cell Receptor γ Gene Rearrangement

Tekijä Yamamoto, Kazuhito, Osada, Hirotaka, Seto, Masao, Ogura, Michinori, Suzuki, Hisamitsu, Utsumi, Kazuhiko R., Oyama, Atsushi, Ariyoshi, Yutaka, Nakamura, Shigeo, Kurita, Souji, Takahashi, Toshitada, Ueda, Ryuzo
Julkaisussa Jpn J Cancer Res (1992)

Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma

Tekijä Ogura, Michinori, Tobinai, Kensei, Hatake, Kiyohiko, Ishizawa, Kenichi, Uike, Naokuni, Uchida, Toshiki, Suzuki, Tatsuya, Aoki, Tomohiro, Watanabe, Takashi, Maruyama, Dai, Yokoyama, Masahiro, Takubo, Takatoshi, Kagehara, Hideaki, Matsushima, Takafumi
Julkaisussa Cancer Sci (2014)

Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma

Tekijä Nakamura, Shigeo, Seto, Masao, Banno, Shogo, Suzuki, Susumu, Koshikawa, Takashi, Kitoh, Kuniyoshi, Kagami, Yoshitoyo, Ogura, Michinori, Yatabe, Yasushi, Kojima, Masaru, Motoori, Tadashi, Takahashi, Toshitada, Ueda, Ryuzo, Suchi, Taizan
Julkaisussa Jpn J Cancer Res (1994)

Phase I/II study of bortezomib‐melphalan‐prednisolone for previously untreated Japanese patients with multiple myeloma

Tekijä Ogawa, Yoshiaki, Suzuki, Kenshi, Sakai, Akira, Iida, Shinsuke, Ogura, Michinori, Tobinai, Kensei, Matsumoto, Morio, Matsue, Kosei, Terui, Yasuhito, Ohashi, Kazuteru, Ishii, Masami, Mukai, Harumi Y., Ando, Kiyoshi, Hotta, Tomomitsu
Julkaisussa Cancer Sci (2013)

Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies

Tekijä Ogura, Michinori, Uchida, Toshiki, Terui, Yasuhito, Hayakawa, Fumihiko, Kobayashi, Yukio, Taniwaki, Masafumi, Takamatsu, Yasushi, Naoe, Tomoki, Tobinai, Kensei, Munakata, Wataru, Yamauchi, Takeshi, Kageyama, Akiko, Yuasa, Miyuki, Motoyama, Masaaki, Tsunoda, Takeshi, Hatake, Kiyohiko
Julkaisussa Cancer Sci (2015)

Phase I/II study of decitabine in patients with myelodysplastic syndrome: A multi‐center study in Japan

Tekijä Oki, Yasuhiro, Kondo, Yutaka, Yamamoto, Kazuhito, Ogura, Michinori, Kasai, Masanobu, Kobayashi, Yukio, Watanabe, Takashi, Uike, Naokuni, Ohyashiki, Kazuma, Okamoto, Shin‐ichiro, Ohnishi, Kazunori, Tomita, Akihiro, Miyazaki, Yasushi, Tohyama, Kaoru, Mukai, Harumi Y., Hotta, Tomomitsu, Tomonaga, Masao
Julkaisussa Cancer Sci (2012)

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study –...

Tekijä Kinoshita, Tomohiro, Watanabe, Takashi, Itoh, Kuniaki, Yoshimura, Kenichi, Tobinai, Kensei, Ogura, Michinori, Yamaguchi, Motoko, Kurosawa, Mitsutoshi, Imaizumi, Yoshitaka, Ota, Shuichi, Kaba, Harumi, Mukai, Kiyoshi, Nakamura, Shigeo, Ohshima, Koichi, Hotta, Tomomitsu, Tsukasaki, Kunihiro, Nagai, Hirokazu, Shimoyama, Masanori
Julkaisussa J Clin Exp Hematop (2021)